TP53 and cancer: Our data also show that Mycoplasma DnaK co-immunoprecipitates with USP10, a key p53 regulator, and this resulted in a reduction of p53-dependent anti-cancer functions, hampering the effect of drugs that rely on p53 activation to exert their anti-cancer effect [78].